HLA-G and cancer: demonstrated that the effects of IFNG are generally pro-tumorigenic during the immune escape stage of cancer immunoediting, in which IFNG increases inhibitory immune checkpoint molecules, including HLA-G, to promote the formation of a tolerant immune microenvironment (29).